Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Oral Solid Dosage Pharmaceutical Formulation Market: By Product Type, By Drug Release Mechanism, By Disease Indication, Pulmonary Arterial Hypertension, Others), By Distribution Channel, and Region Forecast 2019-2030
Oral Solid Dosage Pharmaceutical Formulation Market size was valued at US$ 504.6 billion in 2023 and is poised to grow at a CAGR of 6.6% from 2024-2030. Oral solid dosage pharmaceutical formulation are most widely used dosage forms. They are easy to manufacture and transport due to their increased chemical and physical stability. Oral Solid Dosage Pharmaceutical Formulation Market are cost effective when compared with the other kind of dosage forms. These can be formulated in various flavors in order to mask the unpleasant taste of the formulation and increase the patient compliance. The technological advancements are enabling the manufacturers to formulate new drugs such as sustained release dosage forms which minimize the frequent administration of the drug. The most often utilised medications to treat various medical problems are oral solid dose forms.
In comparison to other dosage forms, oral solid dosage forms are both cost-effective and simple to manufacture. They provide manufacturers with numerous advantages, including trouble-free packaging and transportation, as well as greater chemical and physical stability. Patients can benefit from oral solids as well. Patients frequently choose oral solid dosage forms because of the inherent advantages in dosage administration and the absence of the need for dose measurement. In order to improve patient compliance, they can be made in a variety of flavours and dose formats. Few APIs, for example, have a disagreeable taste, thus they are made in the form of effervescent tablets to ensure patient acceptability and compliance.
Study Period
2024-2030Base Year
2023CAGR
6.6%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Market players are majorly focused on oral solid dosage forms due to convenience and safe way of administration. Increased sedentary and fast paced lifestyle is leading to adopt lifestyle related diseases such as obesity, diabetes. The manufacturers are targeting the population in developing countries in order to enhance the market. A significant boost is observed in the Asia Pacific region owing to increased population. Moreover, the generic manufacturers are playing a major role in the growth of the oral solid dosage pharmaceutical formulation market by introducing generic drugs in the local market. However, the high regulatory requirement is expected to hamper the market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 504.6 billion |
Market CAGR |
6.6% |
By Type |
|
By Drug Release |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
The oral solid dosage pharmaceutical formulation market size was valued at US$ 504.6 billion in 2023 and is poised to grow at a CAGR of 6.6% from 2024-2030.
Asia Pacific is the fastest-growing for oral solid dosage pharmaceutical formulation market
The oral solid dosage pharmaceutical formulation market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1.Executive Summary |
2.Global Oral Solid Dosage Pharmaceutical Formulation Market Introduction |
2.1.Global Oral Solid Dosage Pharmaceutical Formulation Market - Taxonomy |
2.2.Global Oral Solid Dosage Pharmaceutical Formulation Market - Definitions |
2.2.1.Type |
2.2.2.Drug Release |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Oral Solid Dosage Pharmaceutical Formulation Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Oral Solid Dosage Pharmaceutical Formulation Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Tablets |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Lozenges |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Capsules |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Oral Solid Dosage Pharmaceutical Formulation Market By Drug Release, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Sustained Release |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Extended Release |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Instant Release |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Chewable Tablets |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Effervescent Tablets |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Enteric Release |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7.Global Oral Solid Dosage Pharmaceutical Formulation Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Drug Stores |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Online Pharmacies |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Oral Solid Dosage Pharmaceutical Formulation Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Oral Solid Dosage Pharmaceutical Formulation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Tablets |
9.1.2.Lozenges |
9.1.3.Capsules |
9.2. Drug Release Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Sustained Release |
9.2.2.Extended Release |
9.2.3.Instant Release |
9.2.4.Chewable Tablets |
9.2.5.Effervescent Tablets |
9.2.6.Enteric Release |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Drug Stores |
9.3.4.Online Pharmacies |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Oral Solid Dosage Pharmaceutical Formulation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Tablets |
10.1.2.Lozenges |
10.1.3.Capsules |
10.2. Drug Release Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Sustained Release |
10.2.2.Extended Release |
10.2.3.Instant Release |
10.2.4.Chewable Tablets |
10.2.5.Effervescent Tablets |
10.2.6.Enteric Release |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Drug Stores |
10.3.4.Online Pharmacies |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Oral Solid Dosage Pharmaceutical Formulation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Tablets |
11.1.2.Lozenges |
11.1.3.Capsules |
11.2. Drug Release Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Sustained Release |
11.2.2.Extended Release |
11.2.3.Instant Release |
11.2.4.Chewable Tablets |
11.2.5.Effervescent Tablets |
11.2.6.Enteric Release |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Drug Stores |
11.3.4.Online Pharmacies |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Oral Solid Dosage Pharmaceutical Formulation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Tablets |
12.1.2.Lozenges |
12.1.3.Capsules |
12.2. Drug Release Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Sustained Release |
12.2.2.Extended Release |
12.2.3.Instant Release |
12.2.4.Chewable Tablets |
12.2.5.Effervescent Tablets |
12.2.6.Enteric Release |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Drug Stores |
12.3.4.Online Pharmacies |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Oral Solid Dosage Pharmaceutical Formulation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Tablets |
13.1.2.Lozenges |
13.1.3.Capsules |
13.2. Drug Release Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Sustained Release |
13.2.2.Extended Release |
13.2.3.Instant Release |
13.2.4.Chewable Tablets |
13.2.5.Effervescent Tablets |
13.2.6.Enteric Release |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Drug Stores |
13.3.4.Online Pharmacies |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.AstraZeneca Plc. (UK) |
14.2.2.Bristol-Myers Squibb Company (U.S) |
14.2.3.Novartis AG (Switzerland) |
14.2.4.Pfizer Inc. (U.S) |
14.2.5.AbbVie Inc. (U.S) |
14.2.6.Boehringer Ingelheim GmbH (Germany) |
14.2.7.Johnson & Johnson (U.S) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players